nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anemia, iron metabolism, and anemia medication habits in patients undergoing maintenance hemodialysis and peritoneal dialysis are different: a multicenter investigation
|
Liu, Yumei |
|
|
29 |
5 |
p. 573-582 |
artikel |
2 |
Aspartate/alanine aminotransferase ratio and development of chronic kidney disease in non-diabetic men and women: a population-based longitudinal study in Kagawa, Japan
|
Okawa, Yukari |
|
|
29 |
5 |
p. 560-572 |
artikel |
3 |
Assessing masked hypertension and ambulatory arterial stiffness index in children congenital kidney malformations
|
Güngör, Tülin |
|
|
29 |
5 |
p. 662-671 |
artikel |
4 |
Association of diabetic retinopathy with kidney disease progression according to baseline kidney function and albuminuria status in individuals with type 2 diabetes
|
Mori, Tomomi |
|
|
29 |
5 |
p. 607-615 |
artikel |
5 |
Change in kidney volume growth rate and renal outcomes of tolvaptan treatment in autosomal dominant polycystic kidney disease: post-hoc analysis of TEMPO 3:4 trial
|
Higashihara, Eiji |
|
|
29 |
5 |
p. 638-649 |
artikel |
6 |
Correction: Comprehensive review of mitochondrial nephropathy—a renal phenotype in mitochondrial disease: causative genes, clinical and pathological features, diagnosis, prognosis, and treatment
|
Imasawa, Toshiyuki |
|
|
29 |
5 |
p. 690 |
artikel |
7 |
Development and validation of an algorithm for identifying patients undergoing dialysis from patients with advanced chronic kidney disease
|
Imaizumi, Takahiro |
|
|
29 |
5 |
p. 650-661 |
artikel |
8 |
Efficacy and safety of patiromer for non-dialysis and dialysis patients with hyperkalemia: the randomized, placebo-controlled and long-term study
|
Kashihara, Naoki |
|
|
29 |
5 |
p. 548-559 |
artikel |
9 |
Efficacy and safety of rituximab in primary IgA nephropathy: a retrospective study
|
Li, Jingzhen |
|
|
29 |
5 |
p. 616-623 |
artikel |
10 |
Factors associated with awareness of chronic kidney disease, and impact of awareness on renal prognosis
|
Hattori, Akiko |
|
|
29 |
5 |
p. 596-606 |
artikel |
11 |
Genetic aspects of pediatric nephrotic syndrome and anti-nephrin antibodies
|
Horinouchi, Tomoko |
|
|
29 |
5 |
p. 534-540 |
artikel |
12 |
Impact of Fc-gamma receptor IIIA polymorphism on late-onset neutropenia and clinical outcomes in kidney transplant recipients following rituximab induction therapy
|
Tashiro, Yuki |
|
|
29 |
5 |
p. 681-689 |
artikel |
13 |
Luminal flow in the connecting tubule induces afferent arteriole vasodilation
|
Wang, Hong |
|
|
29 |
5 |
p. 541-547 |
artikel |
14 |
Lupus nephritis and related renal disease: review from case series
|
Ubara, Yoshifumi |
|
|
29 |
5 |
p. 507-520 |
artikel |
15 |
The effect of different timings of protein supplementation on variable outcomes in hemodialysis patients: a randomized clinical trial
|
Elsayed, Mohamed Mamdouh |
|
|
29 |
5 |
p. 672-680 |
artikel |
16 |
The health-economic impact of urine albumin-to-creatinine ratio testing for chronic kidney disease in Japanese non-diabetic patients
|
Konta, Tsuneo |
|
|
29 |
5 |
p. 583-595 |
artikel |
17 |
Treatment pattern and clinical outcomes of remdesivir in hospitalized COVID-19 patients with severe chronic kidney disease: a database analysis of acute care hospitals in Japan
|
Yoshida, Manami |
|
|
29 |
5 |
p. 624-637 |
artikel |
18 |
Water and electrolyte abnormalities in novel pharmacological agents for kidney disease and cancer
|
Terashita, Maho |
|
|
29 |
5 |
p. 521-533 |
artikel |